Cargando…
Influence of endpoint definitions on the effect of empagliflozin on major renal outcomes in the EMPEROR‐Preserved trial
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291539/ https://www.ncbi.nlm.nih.gov/pubmed/34459076 http://dx.doi.org/10.1002/ejhf.2334 |
_version_ | 1784749159076593664 |
---|---|
author | Packer, Milton Zannad, Faiez Butler, Javed Filippatos, Gerasimos Ferreira, Joao Pedro Pocock, Stuart J. Brueckmann, Martina Zeller, Cordula Hauske, Sibylle Anker, Stefan D. |
author_facet | Packer, Milton Zannad, Faiez Butler, Javed Filippatos, Gerasimos Ferreira, Joao Pedro Pocock, Stuart J. Brueckmann, Martina Zeller, Cordula Hauske, Sibylle Anker, Stefan D. |
author_sort | Packer, Milton |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9291539 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley & Sons, Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92915392022-07-20 Influence of endpoint definitions on the effect of empagliflozin on major renal outcomes in the EMPEROR‐Preserved trial Packer, Milton Zannad, Faiez Butler, Javed Filippatos, Gerasimos Ferreira, Joao Pedro Pocock, Stuart J. Brueckmann, Martina Zeller, Cordula Hauske, Sibylle Anker, Stefan D. Eur J Heart Fail Research Letter John Wiley & Sons, Ltd. 2021-08-30 2021-10 /pmc/articles/PMC9291539/ /pubmed/34459076 http://dx.doi.org/10.1002/ejhf.2334 Text en © 2021 The Authors. European Journal of Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Research Letter Packer, Milton Zannad, Faiez Butler, Javed Filippatos, Gerasimos Ferreira, Joao Pedro Pocock, Stuart J. Brueckmann, Martina Zeller, Cordula Hauske, Sibylle Anker, Stefan D. Influence of endpoint definitions on the effect of empagliflozin on major renal outcomes in the EMPEROR‐Preserved trial |
title | Influence of endpoint definitions on the effect of empagliflozin on major renal outcomes in the EMPEROR‐Preserved trial |
title_full | Influence of endpoint definitions on the effect of empagliflozin on major renal outcomes in the EMPEROR‐Preserved trial |
title_fullStr | Influence of endpoint definitions on the effect of empagliflozin on major renal outcomes in the EMPEROR‐Preserved trial |
title_full_unstemmed | Influence of endpoint definitions on the effect of empagliflozin on major renal outcomes in the EMPEROR‐Preserved trial |
title_short | Influence of endpoint definitions on the effect of empagliflozin on major renal outcomes in the EMPEROR‐Preserved trial |
title_sort | influence of endpoint definitions on the effect of empagliflozin on major renal outcomes in the emperor‐preserved trial |
topic | Research Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291539/ https://www.ncbi.nlm.nih.gov/pubmed/34459076 http://dx.doi.org/10.1002/ejhf.2334 |
work_keys_str_mv | AT packermilton influenceofendpointdefinitionsontheeffectofempagliflozinonmajorrenaloutcomesintheemperorpreservedtrial AT zannadfaiez influenceofendpointdefinitionsontheeffectofempagliflozinonmajorrenaloutcomesintheemperorpreservedtrial AT butlerjaved influenceofendpointdefinitionsontheeffectofempagliflozinonmajorrenaloutcomesintheemperorpreservedtrial AT filippatosgerasimos influenceofendpointdefinitionsontheeffectofempagliflozinonmajorrenaloutcomesintheemperorpreservedtrial AT ferreirajoaopedro influenceofendpointdefinitionsontheeffectofempagliflozinonmajorrenaloutcomesintheemperorpreservedtrial AT pocockstuartj influenceofendpointdefinitionsontheeffectofempagliflozinonmajorrenaloutcomesintheemperorpreservedtrial AT brueckmannmartina influenceofendpointdefinitionsontheeffectofempagliflozinonmajorrenaloutcomesintheemperorpreservedtrial AT zellercordula influenceofendpointdefinitionsontheeffectofempagliflozinonmajorrenaloutcomesintheemperorpreservedtrial AT hauskesibylle influenceofendpointdefinitionsontheeffectofempagliflozinonmajorrenaloutcomesintheemperorpreservedtrial AT ankerstefand influenceofendpointdefinitionsontheeffectofempagliflozinonmajorrenaloutcomesintheemperorpreservedtrial AT influenceofendpointdefinitionsontheeffectofempagliflozinonmajorrenaloutcomesintheemperorpreservedtrial |